Antibiotic resistance is a bacterial defense mechanism against antibiotics. It can rapidly spread from one bacterium to another. This makes antibiotics increasingly ineffective.
Detailed description
The level of resistances against antibiotics is rising. This is a great challenge for physicians and scientists. Scientists within the DZIF research field “Healthcare-associated and Antibiotic-resistant bacterial Infections” aim to develop new strategies against the development and spread of resistance.
More about “Antibiotic resistance”
Please use the image only in connection with the press release.
Researchers from the German Center for Infection Research (DZIF) at the University of Cologne have conducted a study on the carbapenem-resistant bacterium Acinetobacter baumannii. The pathogen was
Please use the picture only in connection with the press release.
Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogenPseudomonas aeruginosa are particularly feared
DZIF scientist Dr Janko Sattler, a medical specialist at the Institute for Medical Microbiology, Immunology and Hygiene at the University Hospital Cologne, was awarded the bioMérieux Diagnostics Prize
The INCubator for Antibacterial Therapies in Europe, INCATE, can point to an impressive series of successes on its two-year anniversary. With direct contact to more than 180 start-ups and initiatives
Please use the picture only in connection with the press release.
More and more bacterial pathogens are developing resistance. There is an increasing risk that current drugs will no longer be effective against infectious diseases. Scientists around the world are
There are a number of factors responsible for the development of antibiotic resistance. So far, the interactions between pathogens and the complex microbial colonisation (microbiota) of the human body under the selection pressure of antibiotic treatment play a little studied and underestimated role ...
Antibiotics affect the composition and dynamics of the gut microbiome. Treatment with antibiotics not only leads to a loss of biodiversity of microorganisms, but also often favours the selection of
The drug candidate BTZ-043 has a novel mechanism of action and belongs to a new class of substances. Discovered at the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI
